refs[] |
{'index': 0, 'target_release_id': None, 'extra': {'authors': ['WK Smits'], 'doi': '10.1038/nrdp.2016.20', 'unstructured': 'Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ. Clostridium difficile infection. Nat Rev Dis Primers. 2016;2(1):16020. https://doi.org/10.1038/nrdp.2016.20.'}, 'key': '6147_CR1', 'year': 2016, 'container_name': 'Nat Rev Dis Primers', 'title': None, 'locator': '16020'}
{'index': 1, 'target_release_id': None, 'extra': {'authors': ['M Haque'], 'doi': '10.2147/idr.s177247', 'unstructured': 'Haque M, Sartelli M, McKimm J, Abu Bakar M. Health care-associated infections - an overview. Infect Drug Resist. 2018;11:2321–33. https://doi.org/10.2147/IDR.S177247.', 'volume': '11'}, 'key': '6147_CR2', 'year': 2018, 'container_name': 'Infect Drug Resist', 'title': None, 'locator': '2321'}
{'index': 2, 'target_release_id': None, 'extra': {'authors': ['SM McGlone'], 'doi': '10.1111/j.1469-0691.2011.03571.x', 'unstructured': 'McGlone SM, Bailey RR, Zimmer SM, Popovich MJ, Tian Y, Ufberg P, et al. The economic burden of Clostridium difficile. Clin Microbiol Infect. 2012;18(3):282–9. https://doi.org/10.1111/j.1469-0691.2011.03571.x.', 'volume': '18'}, 'key': '6147_CR3', 'year': 2012, 'container_name': 'Clin Microbiol Infect', 'title': None, 'locator': '282'}
{'index': 3, 'target_release_id': None, 'extra': {'authors': ['AM Jones'], 'unstructured': 'Jones AM, Kuijper EJ, Wilcox MH. Clostridium difficile: a European perspective. J Inf Secur. 2013;66(2):115–28.', 'volume': '66'}, 'key': '6147_CR4', 'year': 2013, 'container_name': 'J Inf Secur', 'title': None, 'locator': '115'}
{'index': 4, 'target_release_id': None, 'extra': {'authors': ['E Balsells'], 'doi': '10.7189/jogh.09.010407', 'unstructured': 'Balsells E, Shi T, Leese C, Lyell I, Burrows J, Wiuff C, et al. Global burden of Clostridium difficile infections: a systematic review and meta-analysis. J Glob Health. 2019;9(1):010407. https://doi.org/10.7189/jogh.09.010407.'}, 'key': '6147_CR5', 'year': 2019, 'container_name': 'J Glob Health', 'title': None, 'locator': '010407'}
{'index': 5, 'target_release_id': None, 'extra': {'authors': ['FC Lessa'], 'doi': '10.1093/cid/cis319', 'issue': 'Suppl 2', 'unstructured': 'Lessa FC, Gould CV, McDonald LC. Current status of Clostridium difficile infection epidemiology. Clin Infect Dis. 2012;55(Suppl 2):S65–70. https://doi.org/10.1093/cid/cis319.', 'volume': '55'}, 'key': '6147_CR6', 'year': 2012, 'container_name': 'Clin Infect Dis', 'title': None, 'locator': 'S65'}
{'index': 6, 'target_release_id': None, 'extra': {'authors': ['J Freeman'], 'doi': '10.1128/cmr.00082-09', 'unstructured': 'Freeman J, Bauer MP, Baines SD, Corver J, Fawley WN, Goorhuis B, et al. The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev. 2010;23(3):529–49. https://doi.org/10.1128/CMR.00082-09.', 'volume': '23'}, 'key': '6147_CR7', 'year': 2010, 'container_name': 'Clin Microbiol Rev', 'title': None, 'locator': '529'}
{'index': 7, 'target_release_id': None, 'extra': {'authors': ['SB Debast'], 'doi': '10.1111/1469-0691.12418', 'unstructured': 'Debast SB, Bauer MP, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20:1–26. https://doi.org/10.1111/1469-0691.12418.', 'volume': '20'}, 'key': '6147_CR8', 'year': 2014, 'container_name': 'Clin Microbiol Infect', 'title': None, 'locator': None}
{'index': 8, 'target_release_id': None, 'extra': {'authors': ['LC McDonald'], 'doi': '10.1093/cid/cix1085', 'unstructured': 'McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):e1–e48. https://doi.org/10.1093/cid/cix1085.', 'volume': '66'}, 'key': '6147_CR9', 'year': 2018, 'container_name': 'Clin Infect Dis', 'title': None, 'locator': 'e1'}
{'index': 9, 'target_release_id': None, 'extra': {'authors': ['M Sartelli'], 'doi': '10.1186/s13017-015-0033-6', 'unstructured': 'Sartelli M, Malangoni MA, Abu-Zidan FM, Griffiths EA, Di Bella S, McFarland LV, et al. WSES guidelines for management of Clostridium difficile infection in surgical patients. World J Emerg Surg. 2015;10(1):38. https://doi.org/10.1186/s13017-015-0033-6.', 'volume': '10'}, 'key': '6147_CR10', 'year': 2015, 'container_name': 'World J Emerg Surg', 'title': None, 'locator': '38'}
{'index': 10, 'target_release_id': None, 'extra': {'authors': ['CM Surawicz'], 'doi': '10.1038/ajg.2013.4', 'unstructured': 'Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478–98. https://doi.org/10.1038/ajg.2013.4.', 'volume': '108'}, 'key': '6147_CR11', 'year': 2013, 'container_name': 'Am J Gastroenterol', 'title': None, 'locator': '478'}
{'index': 11, 'target_release_id': None, 'extra': {'authors': ['T Singh'], 'doi': '10.14740/jocmr3854', 'unstructured': 'Singh T, Bedi P, Bumrah K, Singh J, Rai M, Seelam S. Updates in treatment of recurrent Clostridium difficile infection. J Clin Med Res. 2019;11(7):465–71. https://doi.org/10.14740/jocmr3854.', 'volume': '11'}, 'key': '6147_CR12', 'year': 2019, 'container_name': 'J Clin Med Res', 'title': None, 'locator': '465'}
{'index': 12, 'target_release_id': None, 'extra': {'authors': ['D Moher'], 'doi': '10.1136/bmj.b2535', 'issue': 'jul21 1', 'unstructured': 'Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339(jul21 1):b2535. https://doi.org/10.1136/bmj.b2535.', 'volume': '339'}, 'key': '6147_CR13', 'year': 2009, 'container_name': 'BMJ', 'title': None, 'locator': 'b2535'}
{'index': 13, 'target_release_id': None, 'extra': {'unstructured': 'Ovid Search Platform. 2020. Available from: https://ovidsp.ovid.com/. Accessed Jan 2019.'}, 'key': '6147_CR14', 'year': None, 'container_name': None, 'title': None, 'locator': None}
{'index': 14, 'target_release_id': None, 'extra': {'authors': ['European Centre for Disease Prevention and Control'], 'unstructured': 'European Centre for Disease Prevention and Control. Surveillance and disease data for Clostridium difficile infections. 2018. Available from: https://www.ecdc.europa.eu/en/clostridium-difficile-infections/surveillance-and-disease-data.', 'volume-title': 'Surveillance and disease data for Clostridium difficile infections'}, 'key': '6147_CR15', 'year': 2018, 'container_name': 'Surveillance and disease data for Clostridium difficile infections', 'title': None, 'locator': None}
{'index': 15, 'target_release_id': None, 'extra': {'authors': ['C Luchini'], 'doi': '10.13105/wjma.v5.i4.80', 'unstructured': 'Luchini C, Stubbs B, Solmi M, Veronese N. Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa scale. World J Meta-Anal. 2017;5(4):80–4. https://doi.org/10.13105/wjma.v5.i4.80.'}, 'key': '6147_CR16', 'year': 2017, 'container_name': 'World J Meta-Anal', 'title': None, 'locator': '80'}
{'index': 16, 'target_release_id': None, 'extra': {'authors': ['G Wells'], 'unstructured': "Wells G, Shea B, O'Connell D, Peterson J, Welch V, Losos M, et al. Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2019. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.", 'volume-title': 'Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses'}, 'key': '6147_CR17', 'year': 2019, 'container_name': 'Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses', 'title': None, 'locator': None}
{'index': 17, 'target_release_id': None, 'extra': {'authors': ['N-O Huebner'], 'doi': '10.1186/s12879-016-1756-z', 'unstructured': 'Huebner N-O, Dittmann K, Henck V, Wegner C, Kramer A, Action Group Infection P. Epidemiology of multidrug resistant bacterial organisms and Clostridium difficile in German hospitals in 2014: results from a nationwide one-day point prevalence of 329 German hospitals. BMC Infect Dis. 2016;16(1):467. https://doi.org/10.1186/s12879-016-1756-z.', 'volume': '16'}, 'key': '6147_CR18', 'year': 2016, 'container_name': 'BMC Infect Dis', 'title': None, 'locator': '467'}
{'index': 18, 'target_release_id': None, 'extra': {'authors': ['A Jurke'], 'issue': 'SUPPL. 3', 'unstructured': 'Jurke A, Lunemann M, Friedrich AW, Daniels-Haardt I. Description of notifications of severe cases of Clostridium difficile associated diarrhaea in North Rhine-Westphalia. Clin Microbiol Infect. 2012;18(SUPPL. 3):653.', 'volume': '18'}, 'key': '6147_CR19', 'year': 2012, 'container_name': 'Clin Microbiol Infect', 'title': None, 'locator': '653'}
{'index': 19, 'target_release_id': None, 'extra': {'authors': ['A Penit'], 'doi': '10.1016/j.medmal.2016.01.007', 'unstructured': 'Penit A, Bemer P, Besson J, Cazet L, Bourigault C, Juvin ME, et al. Community-acquired Clostridium difficile infections. Med Mal Infect. 2016;46(3):131–9. https://doi.org/10.1016/j.medmal.2016.01.007.', 'volume': '46'}, 'key': '6147_CR20', 'year': 2016, 'container_name': 'Med Mal Infect', 'title': None, 'locator': '131'}
{'index': 20, 'target_release_id': None, 'extra': {'authors': ['C Sheitoyan-Pesant'], 'doi': '10.1093/cid/civ958', 'unstructured': 'Sheitoyan-Pesant C, Abou Chakra CN, Pépin J, Marcil-Héguy A, Nault V, Valiquette L. Clinical and healthcare burden of multiple recurrences of Clostridium difficile infection. Clin Infect Dis. 2015;62(5):574–80. https://doi.org/10.1093/cid/civ958.', 'volume': '62'}, 'key': '6147_CR21', 'year': 2015, 'container_name': 'Clin Infect Dis', 'title': None, 'locator': '574'}
{'index': 21, 'target_release_id': None, 'extra': {'authors': ['European Centre for Disease Prevention and Control'], 'unstructured': 'European Centre for Disease Prevention and Control. Healthcare-associated infections: Clostridium difficile infections. In: ECDC. Annual epidemiological report for 2016; 2018.', 'volume-title': 'ECDC. Annual epidemiological report for 2016'}, 'key': '6147_CR22', 'year': 2018, 'container_name': 'ECDC. Annual epidemiological report for 2016', 'title': None, 'locator': None}
{'index': 22, 'target_release_id': None, 'extra': {'authors': ['KC Katz'], 'doi': '10.1503/cmaj.180013', 'issue': '25', 'unstructured': 'Katz KC, Golding GR, Choi KB, Pelude L, Amaratunga KR, Taljaard M, et al. The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015). CMAJ. 2018;190(25):E758–E65. https://doi.org/10.1503/cmaj.180013.', 'volume': '190'}, 'key': '6147_CR23', 'year': 2018, 'container_name': 'CMAJ', 'title': None, 'locator': 'E758'}
{'index': 23, 'target_release_id': None, 'extra': {'authors': ['ME Evans'], 'doi': '10.1086/677151', 'unstructured': 'Evans ME, Simbartl LA, Kralovic SM, Jain R, Roselle GA. Clostridium difficile infections in veterans health administration acute care facilities. Infect Control Hosp Epidemiol. 2014;35(8):1037–42. https://doi.org/10.1086/677151.', 'volume': '35'}, 'key': '6147_CR24', 'year': 2014, 'container_name': 'Infect Control Hosp Epidemiol', 'title': None, 'locator': '1037'}
{'index': 24, 'target_release_id': None, 'extra': {'authors': ['P Gastmeier'], 'doi': '10.1016/s0924-8579(09)70011-1', 'issue': 'Suppl 1', 'unstructured': 'Gastmeier P, Weitzel-Kage D, Behnke M, Eckmanns T. Surveillance of Clostridium difficile-associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS). Int J Antimicrob Agents. 2009;33(Suppl 1):S19–23. https://doi.org/10.1016/S0924-8579(09)70011-1.', 'volume': '33'}, 'key': '6147_CR25', 'year': 2009, 'container_name': 'Int J Antimicrob Agents', 'title': None, 'locator': 'S19'}
{'index': 25, 'target_release_id': None, 'extra': {'authors': ['C Slimings'], 'doi': '10.5694/mja13.11153', 'unstructured': 'Slimings C, Armstrong P, Beckingham WD, Bull AL, Hall L, Kennedy KJ, et al. Increasing incidence of Clostridium difficile infection, Australia, 2011-2012. Med J Aust. 2014;200(5):272–6. https://doi.org/10.5694/mja13.11153.', 'volume': '200'}, 'key': '6147_CR26', 'year': 2014, 'container_name': 'Med J Aust', 'title': None, 'locator': '272'}
{'index': 26, 'target_release_id': None, 'extra': {'authors': ['J Guardiola'], 'doi': '10.1016/s1873-9946(12)60436-x', 'issue': 'SUPPL. 1', 'unstructured': 'Guardiola J, Lobaton Ortega T, Rodriguez-Moranta F, Rodriguez Alonso L, Parra Cancino C, Duenas E. Nosocomial Clostridium difficile infection (CDI) incidence in two Spanish referral hospitals. Secular trend during the last decade. J Crohns Colitis. 2012;6(SUPPL. 1):S176.'}, 'key': '6147_CR27', 'year': 2012, 'container_name': 'J Crohns Colitis', 'title': None, 'locator': 'S176'}
{'index': 27, 'target_release_id': None, 'extra': {'authors': ['H Kanamori'], 'doi': '10.1017/ice.2015.142', 'issue': '10', 'unstructured': 'Kanamori H, Weber DJ, Dibiase LM, Sickbert-Bennett EE, Brooks R, Teal L, et al. Longitudinal trends in all healthcare-associated infections through comprehensive hospital-wide surveillance and infection control measures over the past 12 years: substantial burden of healthcare-associated infections outside of intensive care units and "other" types of infection. Infect Control Hosp Epidemiol. 2015;36(10):1139–47. https://doi.org/10.1017/ice.2015.142.', 'volume': '36'}, 'key': '6147_CR28', 'year': 2015, 'container_name': 'Infect Control Hosp Epidemiol', 'title': None, 'locator': '1139'}
{'index': 28, 'target_release_id': None, 'extra': {'authors': ['N Khanafer'], 'issue': '23', 'unstructured': 'Khanafer N, Oltra L, Hulin M, Dauwalder O, Vandenesch F, Vanhems P. Clostridium difficile infection in a French university hospital Eight years of prospective surveillance study. Medicine (United States). 2016;95(23):e3874.', 'volume': '95'}, 'key': '6147_CR29', 'year': 2016, 'container_name': 'Medicine (United States)', 'title': None, 'locator': 'e3874'}
{'index': 29, 'target_release_id': None, 'extra': {'authors': ['G Roncarati'], 'doi': '10.3390/ijerph14010061', 'unstructured': 'Roncarati G, Dallolio L, Leoni E, Panico M, Zanni A, Farruggia P. Surveillance of Clostridium difficile infections: results from a six-year retrospective study in nine hospitals of a north Italian local health authority. Int J Environ Res Public Health. 2017;14(1):61. https://doi.org/10.3390/ijerph14010061.', 'volume': '14'}, 'key': '6147_CR30', 'year': 2017, 'container_name': 'Int J Environ Res Public Health', 'title': None, 'locator': '61'}
{'index': 30, 'target_release_id': None, 'extra': {'authors': ['I Yoshikawa'], 'issue': '5 Supplement 1', 'unstructured': 'Yoshikawa I, Kumei S, Watanabe T, Kume K, Harada M. The incidence and trend of Clostridium difficile infection at a Japanese university hospital from 2005 to 2014. United Eur Gastroenterol J. 2016;4(5 Supplement 1):A650–A1.'}, 'key': '6147_CR31', 'year': 2016, 'container_name': 'United Eur Gastroenterol J', 'title': None, 'locator': 'A650'}
{'index': 31, 'target_release_id': None, 'extra': {'authors': ['Public Health England'], 'unstructured': 'Public Health England. Clostridium difficile (C. difficile) infection: annual data: GOV.UK; 2018. Available from: https://www.gov.uk/government/statistics/clostridium-difficile-infection-annual-data', 'volume-title': 'Clostridium difficile (C. difficile) infection: annual data'}, 'key': '6147_CR32', 'year': 2018, 'container_name': 'Clostridium difficile (C. difficile) infection: annual data', 'title': None, 'locator': None}
{'index': 32, 'target_release_id': None, 'extra': {'authors': ['National Reference Centre (NRZ)'], 'unstructured': 'National Reference Centre (NRZ). Modul CDAD-KISS Referenzdaten. 2017.', 'volume-title': 'Modul CDAD-KISS Referenzdaten.'}, 'key': '6147_CR33', 'year': 2017, 'container_name': 'Modul CDAD-KISS Referenzdaten.', 'title': None, 'locator': None}
{'index': 33, 'target_release_id': None, 'extra': {'authors': ['ME Charlson'], 'doi': '10.1016/0021-9681(87)90171-8', 'unstructured': 'Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83. https://doi.org/10.1016/0021-9681(87)90171-8.', 'volume': '40'}, 'key': '6147_CR34', 'year': 1987, 'container_name': 'J Chronic Dis', 'title': None, 'locator': '373'}
{'index': 34, 'target_release_id': None, 'extra': {'authors': ['P Viale'], 'doi': '10.1186/s12879-016-1961-9', 'unstructured': 'Viale P, Frasson S, Cipollini F, Menichetti F, Petrosillo N, Brunati S, et al. Epidemiology and outcome of Clostridium difficile infections in patients hospitalized in internal medicine: findings from the nationwide FADOI-PRACTICE study. BMC Infect Dis. 2016;16(1):656.', 'volume': '16'}, 'key': '6147_CR35', 'year': 2016, 'container_name': 'BMC Infect Dis', 'title': None, 'locator': '656'}
{'index': 35, 'target_release_id': None, 'extra': {'authors': ['NHS Improvement'], 'unstructured': 'NHS Improvement. CDI objectives for NHS Organisations for 2019. 2019.', 'volume-title': 'CDI objectives for NHS Organisations for 2019'}, 'key': '6147_CR36', 'year': 2019, 'container_name': 'CDI objectives for NHS Organisations for 2019', 'title': None, 'locator': None}
{'index': 36, 'target_release_id': None, 'extra': {'unstructured': 'World Health Organization. Ten global health issues to track in 2021. Geneva; 2020. Available from: https://www.who.int/news-room/spotlight/10-global-health-issues-to-track-in-2021'}, 'key': '6147_CR37', 'year': None, 'container_name': None, 'title': None, 'locator': None}
{'index': 37, 'target_release_id': None, 'extra': {'unstructured': 'Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2019. Atlanta: U.S. Department of Health and Human Services, CDC; 2019.'}, 'key': '6147_CR38', 'year': None, 'container_name': None, 'title': None, 'locator': None}
{'index': 38, 'target_release_id': None, 'extra': {'doi': '10.1093/cid/ciaa124', 'unstructured': 'Brown KA, Langford B, Schwartz KL, Diong C, Garber G, Daneman N. Antibiotic prescribing choices and their comparative C. difficile infection risks: a longitudinal case-cohort study. Clin Infect Dis. 2020;72(5):836–44.'}, 'key': '6147_CR39', 'year': None, 'container_name': None, 'title': None, 'locator': None}
{'index': 39, 'target_release_id': None, 'extra': {'authors': ['N Daneman'], 'doi': '10.1503/cmaj.161437', 'issue': '25', 'unstructured': 'Daneman N, Campitelli MA, Giannakeas V, Morris AM, Bell CM, Maxwell CJ, et al. Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities. CMAJ. 2017;189(25):E851–E60. https://doi.org/10.1503/cmaj.161437.', 'volume': '189'}, 'key': '6147_CR40', 'year': 2017, 'container_name': 'CMAJ', 'title': None, 'locator': 'E851'}
{'index': 40, 'target_release_id': None, 'extra': {'authors': ['CI Fernandez-Lazaro'], 'doi': '10.1093/cid/ciy1130', 'unstructured': 'Fernandez-Lazaro CI, Brown KA, Langford BJ, Daneman N, Garber G, Schwartz KL. Late-career physicians prescribe longer courses of antibiotics. Clin Infect Dis. 2019;69(9):1467–75. https://doi.org/10.1093/cid/ciy1130.', 'volume': '69'}, 'key': '6147_CR41', 'year': 2019, 'container_name': 'Clin Infect Dis', 'title': None, 'locator': '1467'}
{'index': 41, 'target_release_id': None, 'extra': {'authors': ['F Di Gennaro'], 'doi': '10.1016/j.jgar.2020.08.022', 'unstructured': "Di Gennaro F, Marotta C, Amicone M, Bavaro DF, Bernaudo F, Frisicale EM, et al. Italian young doctors' knowledge, attitudes and practices on antibiotic use and resistance: a national cross-sectional survey. J Glob Antimicrob Resist. 2020;23:167–73. https://doi.org/10.1016/j.jgar.2020.08.022.", 'volume': '23'}, 'key': '6147_CR42', 'year': 2020, 'container_name': 'J Glob Antimicrob Resist', 'title': None, 'locator': '167'}
{'index': 42, 'target_release_id': None, 'extra': {'authors': ['National Institute for Health and Care Excellence'], 'unstructured': 'National Institute for Health and Care Excellence. NICE impact: antimicrobial resistance. 2018.', 'volume-title': 'NICE impact: antimicrobial resistance'}, 'key': '6147_CR43', 'year': 2018, 'container_name': 'NICE impact: antimicrobial resistance', 'title': None, 'locator': None}
{'index': 43, 'target_release_id': None, 'extra': {'authors': ['JH Song'], 'doi': '10.5009/gnl18071', 'unstructured': 'Song JH, Kim YS. Recurrent Clostridium difficile infection: risk factors, treatment, and prevention. Gut Liver. 2019;13(1):16–24. https://doi.org/10.5009/gnl18071.', 'volume': '13'}, 'key': '6147_CR44', 'year': 2019, 'container_name': 'Gut Liver', 'title': None, 'locator': '16'}
{'index': 44, 'target_release_id': None, 'extra': {'authors': ['L Furuya-Kanamori'], 'doi': '10.1017/ice.2014.39', 'unstructured': 'Furuya-Kanamori L, Stone JC, Clark J, McKenzie SJ, Yakob L, Paterson DL, et al. Comorbidities, exposure to medications, and the risk of community-acquired Clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2015;36(2):132–41. https://doi.org/10.1017/ice.2014.39.', 'volume': '36'}, 'key': '6147_CR45', 'year': 2015, 'container_name': 'Infect Control Hosp Epidemiol', 'title': None, 'locator': '132'}
{'index': 45, 'target_release_id': None, 'extra': {'authors': ['MD Zilberberg'], 'doi': '10.1111/jgs.14236', 'unstructured': 'Zilberberg MD, Shorr AF, Wang L, Baser O, Yu H. Development and validation of a risk score for Clostridium difficile infection in Medicare beneficiaries: a population-based cohort study. J Am Geriatr Soc. 2016;64(8):1690–5. https://doi.org/10.1111/jgs.14236.', 'volume': '64'}, 'key': '6147_CR46', 'year': 2016, 'container_name': 'J Am Geriatr Soc', 'title': None, 'locator': '1690'}
|